“…Following initial studies in China, coupled with the findings of Gautret et al (2020) (Boulware et al, 2020;Das et al, 2020;Cortegiani et al, 2020;Gao et al, 2020;Gautret et al, 2020), its use was endorsed among a number of governments and medical societies (Bokpe, 2020;Channnel News Asia, 2020;East African, 2020;Rich, 2020;Sciama, 2020;Tilangi et al, 2020). However, the lack of a comparator arm in the initial studies has been heavily criticised coupled with concerns with sideeffects including cardiac side-effects with hydroxychloroquine (International Society of Antimicrobial Chemotherapy, 2020; Gautret et al, 2020;ISAC/ Elsevier, 2020;Borba et al, 2020;Ferner and Aronson, 2020;Littlejohn, 2020) as well as reports of fatal overdoses (Abena et al, 2020;Das et al, 2020;GuruGamer, 2020;Nga et al, 2020;Politi, 2020). Recent studies have failed to demonstrate any clinical benefit for both the prevention and treatment of COVID-19 (Boulware et al, 2020;Geleris et al, 2020;Recovery Trial, 2020a;Rosenberg et al, 2020).…”